- Keynote Speaker: Luigi Naldini
- Alessia Cavazza - Preclinical Development of Gene Editing Therapies
- André Choulika - From Allogeneic CAR-T Cells to SMART-CART to Fight Solid Tumors
- André Cohnen - Identifying and Engineering Orthogonal and Synthetic RNA-Guided Nucleases (sRGN)
- Andrew Bellinger - Transforming the Care of Cardiovascular Disease Through Single-course Gene Editing Medicines
- Angelo Lombardo - Exploiting Targeted Epigenome Editing for Therapeutic Applications
- Anna Cereseto - Identification and Evolution of Novel CRISPR-Cas Systems from the Human Microbiome
- Antonio Casini - A Novel Portfolio Approach to CRISPR-based Gene Therapies with Tailored Advantages for Human Therapeutics
- Avencia Sanchez-Mejias Garcia - FiCAT Gene Writing Platform for Advanced Therapies
- Ashley Jacobi - End-to-End Tools for Interrogation of CRISPR-Cas Associated Genotoxicity
- Ayal Hendel - Find-and-replace CRISPR Genome Editing HDR2.0: a Promising Therapeutic Strategy
- Ben P. Kleinstiver - Engineered CRISPR Technologies to Improve Genome Editing
- Bernhard Schmierer - CRISPR Functional Genomics as a Tool in Drug Discovery.
- Christian Groendahl - Pioneering Precision Medicines using Microbial CRISPR Gene Therapy
- Daniel Schraivogel - With Technology to Biology: The Single-Cell Functional Genomics Revolution
- Fan Zhou - Novel DNA Payloads and One-Stop CRISPR Toolbox Accelerate Non-Viral Gene Editing Therapeutics Development
- Fiona M. Behan - Identification of Novel Oncology Targets using a Combination of Functional Genomics Approaches & Machine Learning Tools
- Howard Wu - Less is More: Efficient Novel Non-Viral Immune Cell Engineering With Precise Genomic Integration
- Jan Gorodkin - Computational CRISPR/Cas9 gRNA Design
- Jan Nelis - Project Delta Force: Upregulating Delta Globin as a New Avenue to Treat Hemoglobinopathies
- Jin Chen - Functional Genomics Tools to Dissect Genetic Networks of Rejuvenation
- Karim Benabdellah El Khlanji - Connecting Innovators: CA21113 2nd Year Journey in Fostering Collaborative Networks for Breakthroughs in Genome Editing to Treat Human Diseases (GenE-Humdi COST action)
- Karina Thorn - Transforming Gene Therapy from the Few to the Many
- Kevin Holden - Enabling GMP Production of sgRNA for CRISPR-based Cell and Gene Therapies
- Laura Sepp-Lorenzino - Realizing the Promise of CRISPR Therapeutics
- Manuel Kaulich - PRCISR CRISPR: How Prior Knowledge can Drive Hit Confidence in Perturbation Genomics.
- Marcello Maresca - Pharmacological Interventions to Enhance Genome Editing Precision
- Marianne Carlon - Base and Prime Editing Strategies to Re-write CFTR Mutations Causing Cystic Fibrosis – Validation in Patient Derived Cell Models
- Nikhil Gupta - Advancing Oncology Drug Discovery through Pooled CRISPR Screening
- Paul Diehl - Flexible and Scalable Genetic Screens for Discovery and Characterization of Novel Therapeutic Targets
- Paula Rio - Implementation of Gene Editing to Correct Hematopoietic Stem Cells from Fanconi Anemia Patients
- Pia Johansson - CRISPR and Human Induced Pluripotent Stem Cells - the Magic Duo for Medical Research
- Rasmus O. Bak - Genetic and Transcriptional Engineering of Primary Human Blood Cells
- Roberto Nitsch - Deciphering Cas9 immunogenicity
- Samantha Maragh - Updated Outcomes of Variant Detection and Quantitation from the first NIST Genome Editing Consortium Interlab Study
- Sidsel Alsing - Xdrop®: Changing the Approach to Gene Editing Validation and Single-Cell Functional Assays
- Seung Wook Yang - CRISPR-Based Functional Genomic Characterization of Mechanisms of Action of Degraders for Targeted Protein Degradation
- Simon Reed - INDUCE-Seq: Ensuring the Safe Development of Cell and Gene Therapies by Gene Editing
- Simone Spuler - Precisely Edited Primary Human Muscle Stem Cells as an ATMP in Muscular Dystrophies
- Stefano Stella - Optimized Base Editors using Cas12a-Engineered Variants.
- Toni Cathomen - New insights into On- and Off-Target Effects of Genome Editing Tools
- Waseem Qasim - Genome Edited Therapeutic T Cells
- Xavier Duportet - Translating In Vivo Gene Editing to the Microbiome
- Yonglun Luo - Advancing CRISPR Medicine by Probing the Detection, Design, and Delivery
- Zhenya Ivakine - Deciphering the Code of Cancer: A Deep Dive into Variants with Saturation Prime Editing
- CRISPRMED24 Workshops - Workshop - Tools: fully booked | Workshop - Delivery: fully booked | Workshop - Safety: one seat left | Workshop - CRISPR Medicine: 6 seats left | Reserve your seat today or sign up for the waitlist - send an email to: info@crisprmedicineconference.com.
- Oral presentations - Abstract submission closed. 20 abstracts will be selected for oral presentations. Will be announced February 29th.
- Virtual Event - If you can not attend the in-person event in Copenhagen 23-25 April, we will have a virtual event the 22nd April, where anyone can register and submit abstract for the virtual poster session. When you register for the virtual event, you will also get access on-demand to all the presentations from the in-person event after the conference.
- All accepted abstracts for the in-person and virtual poster sessions, will also be shared on CRISPR Medicine News, CMN.
Welcome to Mission Bio and OMNI Life Science - Our new CRISPRMED24 sponsors and exhibitors.
Remember to follow the ongoing Clinical Trials using a Gene Editing Tool here
